Tadalafil shows potential as a diabetes treatment

Written by | 17 May 2023

In a small feasibility study, subjects with type 2 diabetes achieved significant improvement in long-term blood sugar levels following treatment with high-dose tadalafil, an erectile dysfunction drug.  Tadalafil […]

Semaglutide for obesity treatment

Written by | 13 May 2023

Alex Miras is Professor of Endocrinology at the University of Ulster, UK and is an expert in obesity management and research. In 2021 a trial of semaglutide for […]

Could semaglutide prevent cardiometabolic disease?

Written by | 12 May 2023

Professor Alex Miras, consultant endocrinologist at the University of Ulster, takes the view that obesity is a disease. He explains why this is and how the SELECT trial […]

Do I need semaglutide and how can I get it?

Written by | 11 May 2023

Semaglutide works well on its own as obesity treatment but it works even better with the support and guidance of a multi-disciplinary weight-management team, according to Alex Miras, […]

NICE recommends semaglutide for obesity

Written by | 10 May 2023

In March 2023 the National Institute for Health and Care Excellence (NICE) published Technology Appraisal Guidance for semaglutide for obesity. Professor Alex Miras explains the guidance and its […]

Semaglutide – a game-changer in obesity management

Written by | 9 May 2023

Alex Miras is Professor of Endocrinology at the University of Ulster, UK and is an expert in obesity management and research. In 2021 a trial of semaglutide for […]

Use age, not weight, to screen for diabetes

Written by | 26 Mar 2023

Focus on age, not weight, to capture the greatest number of people in all racial and ethnic groups with prediabetes and diabetes, reports a new Northwestern Medicine study. […]

Another step toward an insulin tablet

Written by | 15 Jan 2023

For the millions of people living with diabetes, insulin is a life-saving drug. Unlike many other medicines, though, insulin cannot be easily delivered by swallowing a pill — […]

Findings support repurposing rheumatoid arthritis drug auranofin for diabetes

Written by | 20 Oct 2022

Researchers at Baylor College of Medicine and collaborating institutions discovered that the rheumatoid arthritis drug auranofin can potentially be repurposed to improve diabetes-associated symptoms. The study, which was […]

Team developing oral insulin tablet sees breakthrough results

Written by | 3 Sep 2022

A team of University of British Columbia researchers working on developing oral insulin tablets as a replacement for daily insulin injections have made a game-changing discovery. Researchers have […]

‘Smart necklace’ biosensor may track health status through sweat

Written by | 24 Jul 2022

Researchers have successfully tested a device that may one day use the chemical biomarkers in sweat to detect changes in a person’s health. In a new study published […]

Not enough men in their 40s are getting screened for diabetes, study finds

Written by | 19 Jul 2022

Not enough men in Alberta, Canada — especially those in their 40s — are getting tested for diabetes, putting them at risk for heart disease, cancer and other […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.